GE HealthCare Technologies Inc. (GEHC) Stock Forecast & Price Target
GE HealthCare Technologies Inc. · NASDAQ
$66.77-2.10 (-3.04%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering GE HealthCare Technologies Inc, 8 rate it Buy or better, 9 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $14.00 to $105.00 (about 7.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $78.00 sits 17% above the current $66.77. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.60 next quarter toward $5.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Moderate Buy
Strong Buy00%
Buy847%
Hold953%
Sell00%
Strong Sell00%
Based on 17 analysts giving stock ratings to GE HealthCare Technologies Inc.
As of Sep, 8 of 17 firms rate GEHC a Buy (9 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GEHC EPS & revenue forecast
EPS · NEXT QUARTER
$1.60
Range $1.48 – $1.68 · 14 analysts · +11% YoY
Next period, 14 analysts expect GE HealthCare Technologies Inc. to earn $1.60 a share (range $1.48 – $1.68), versus $1.44 a year earlier. Full-year consensus is $4.93, growing to $5.41 the year after.
REVENUE · NEXT QUARTER
$5.9B
Range $5.8B – $6.0B · 14 analysts · +4% YoY
Revenue is expected to reach $5.9B (range $5.8B – $6.0B), +4.2% year-over-year. Full-year consensus is $21.7B, rising to $22.7B next year.
Top analysts covering GE HealthCare Technologies Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GEHC.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$85.00+27.3% to target
Overall win rate
46%
+ Follow
#2
Jason Bednar
Piper Sandler · Rank #276
Buy
$74.00+10.8% to target
Overall win rate
35%
+ Follow
#3
Ryan Zimmerman
BTIG
Buy
$79.00+18.3% to target
Coverage
—
+ Follow
#4
GD
Graham Doyle
UBS
Hold
$73.00+9.3% to target
Coverage
—
+ Follow
#5
Joanne Wuensch
Citigroup
Hold
$75.00+12.3% to target
Coverage
—
+ Follow
GEHC stock forecast FAQ
What is GEHC's average 12-month price target?+
The 15 analysts with a live target average $78.00 for GE HealthCare Technologies Inc. over the next 12 months, ranging from a $105.00 high to a $14.00 low.
Is GEHC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 17 analyst ratings, 8 are Buy or Strong Buy, 9 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for GEHC?+
The Street-high target is $105.00 (Jefferies), and the Street-low is $14.00. The average of all 15 active targets is $78.00.
How many Wall Street analysts cover GEHC?+
17 analysts have an active rating on GE HealthCare Technologies Inc., and 15 firms carry a live 12-month price target.
Who is the most accurate analyst covering GEHC?+
Among analysts who currently cover GEHC, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $85.00 target.
What is GE HealthCare Technologies Inc.'s projected EPS for next quarter?+
The consensus estimate is $1.60 per share (range $1.48 – $1.68) across 14 analysts. Full-year EPS is projected at $4.93, rising to $5.41 the following year.
How much revenue is GE HealthCare Technologies Inc. expected to report next quarter?+
Consensus revenue is $5.9B (range $5.8B – $6.0B). Full-year revenue is projected at $21.7B, growing to $22.7B next year.
Have analysts been upgrading or downgrading GEHC lately?+
As of Sep, 8 of 17 firms rate GEHC a Buy (9 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GEHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
